ANTHONY GARCIA: Open Payments
NPI 1326894023 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,276 in 46 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $657 · 2025 $1,276
Food & beverage: $1,276
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 12 | $461 |
| ACADIA Pharmaceuticals Inc | 9 | $158 |
| Otter Pharmaceuticals, LLC | 3 | $103 |
| SpringWorks Therapeutics, Inc. | 2 | $54 |
| Eisai Inc. | 2 | $53 |
| HARMONY BIOSCIENCES LLC | 2 | $52 |
| UCB, Inc. | 2 | $51 |
| EMD Serono, Inc. | 1 | $43 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
| Genentech USA, Inc. | 1 | $28 |
Products named: XYWAV, NUPLAZID, SYMPAZAN, GOMEKLI, Leqembi, WAKIX, Rystiggo, INGREZZA.
Industry payments across TX — which companies pay providers there.
